Alpine Peaks Capital, LP Maravai Lifesciences Holdings, Inc. Transaction History

Alpine Peaks Capital, LP

$115 Million
Q4 2024

A detailed history of Alpine Peaks Capital, LP transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Alpine Peaks Capital, LP holds 204,000 shares of MRVI stock, worth $640,560. This represents 0.97% of its overall portfolio holdings.

Number of Shares

204,000

Previous 279,024 26.89%

Holding current value

$640,560

Previous $2.32 Million 52.07%

% of portfolio

0.97%

Previous 1.46%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$4.42 - $8.5 $331,606 - $637,704	-75,024 Reduced 26.89%	204,000 $1.11 Million
Q3 2024 Nov 14, 2024	SELL	$6.84 - $9.73 $122,271 - $173,933	-17,876 Reduced 6.02%	279,024 $2.32 Million
Q2 2024 Aug 13, 2024	SELL	$6.87 - $11.34 $522,120 - $861,840	-76,000 Reduced 20.38%	296,900 $2.13 Million
Q1 2024 May 15, 2024	SELL	$5.11 - $8.76 $163,520 - $280,320	-32,000 Reduced 7.9%	372,900 $3.23 Million
Q4 2023 Feb 14, 2024	BUY	$4.7 - $9.87 $214,320 - $450,071	45,600 Added 12.69%	404,900 $2.65 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $12.85 $273,066 - $383,906	29,876 Added 9.07%	359,300 $3.59 Million
Q2 2023 Aug 11, 2023	BUY	$12.09 - $15.0 $3.98 Million - $4.94 Million	329,424 New	329,424 $4.09 Million
Q1 2023 May 12, 2023	BUY	$12.99 - $16.48 $3.12 Million - $3.96 Million	240,500 New	240,500 $3.37 Million
Q4 2022 Feb 14, 2023	BUY	$12.5 - $24.78 $2.27 Million - $4.5 Million	181,500 New	181,500 $2.6 Million

Others Institutions Holding MRVI

# of Institutions

203

Shares Held

138M

Call Options Held

271K

Put Options Held

37.6K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $413M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Peaks Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Peaks Capital, LP with notifications on news.

Account

Alpine Peaks Capital, LP Maravai Lifesciences Holdings, Inc. Transaction History